Form 4: Intuitive Surgical SVP Mark Brosius Sells Shares Under 10b5-1 Trading Plan

Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, sold a total of 1,476 shares of common stock between March 4th and March 6th, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Mark Brosius, a Senior Vice President at Intuitive Surgical, sold shares of the company's common stock.
• The sales occurred on three consecutive days: March 4, 2025, March 5, 2025, and March 6, 2025.
• On each day, 492 shares were sold.
• The prices per share were $563.69 on March 4, $554.17 on March 5, and $558.95 on March 6.
• The transactions were executed under a pre-existing trading plan that complies with SEC Rule 10b5-1.
• Following these transactions, Mr. Brosius directly owns 2,580 shares of Intuitive Surgical stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by an executive, executed under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Executive stock sales are a common occurrence and are often part of pre-planned diversification strategies. The use of a 10b5-1 plan indicates that the sales were arranged in advance to avoid any potential accusations of insider trading.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates